JMP Securities Reiterates Outperform Rating for Vertex Pharmaceuticals Incorporated
's stock had its "outperform" rating restated by research analysts at JMP Securities in a research note issued to investors on Wednesday, The Fly reports. A number of other equities analysts have also issued reports on the company.
from Biotech News
0 Comments